Spectra Products Inc.’s (CVE:SSA) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Mar 13, 2024
spectra-products-inc.’s-(cve:ssa)-stock-has-shown-weakness-lately-but-financial-prospects-look-decent:-is-the-market-wrong?

With its stock down 18% over the past week, it is easy to disregard Spectra Products (CVE:SSA). But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. Specifically, we decided to study Spectra Products’ ROE in this article.

ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. Simply put, it is used to assess the profitability of a company in relation to its equity capital.

See our latest analysis for Spectra Products

How Do You Calculate Return On Equity?

Return on equity can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders’ Equity

So, based on the above formula, the ROE for Spectra Products is:

11% = CA$205k ÷ CA$1.9m (Based on the trailing twelve months to September 2023).

The ‘return’ is the income the business earned over the last year. That means that for every CA$1 worth of shareholders’ equity, the company generated CA$0.11 in profit.

What Has ROE Got To Do With Earnings Growth?

So far, we’ve learned that ROE is a measure of a company’s profitability. Depending on how much of these profits the company reinvests or “retains”, and how effectively it does so, we are then able to assess a company’s earnings growth potential. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don’t have the same features.

A Side By Side comparison of Spectra Products’ Earnings Growth And 11% ROE

To start with, Spectra Products’ ROE looks acceptable. Further, the company’s ROE is similar to the industry average of 10%. For this reason, Spectra Products’ five year net income decline of 19% raises the question as to why the decent ROE didn’t translate into growth. Based on this, we feel that there might be other reasons which haven’t been discussed so far in this article that could be hampering the company’s growth. These include low earnings retention or poor allocation of capital.

As a next step, we compared Spectra Products’ performance with the industry and found thatSpectra Products’ performance is depressing even when compared with the industry, which has shrunk its earnings at a rate of 7.7% in the same period, which is a slower than the company.

past-earnings-growth
TSXV:SSA Past Earnings Growth March 13th 2024

Earnings growth is a huge factor in stock valuation. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. Is Spectra Products fairly valued compared to other companies? These 3 valuation measures might help you decide.

Is Spectra Products Making Efficient Use Of Its Profits?

Spectra Products doesn’t pay any dividend, meaning that the company is keeping all of its profits, which makes us wonder why it is retaining its earnings if it can’t use them to grow its business. So there could be some other explanations in that regard. For instance, the company’s business may be deteriorating.

Summary

On the whole, we do feel that Spectra Products has some positive attributes. Although, we are disappointed to see a lack of growth in earnings even in spite of a high ROE and and a high reinvestment rate. We believe that there might be some outside factors that could be having a negative impact on the business. While we won’t completely dismiss the company, what we would do, is try to ascertain how risky the business is to make a more informed decision around the company. You can see the 4 risks we have identified for Spectra Products by visiting our risks dashboard for free on our platform here.

Valuation is complex, but we’re helping make it simple.

Find out whether Spectra Products is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Leave a comment